31.9 F
New York
Friday, December 2, 2022



Marty Rosenberg joins the Board of Scientific Advisors at Microvascular Therapeutics.

Related Articles

NetQuest’s Network Security Broker Delivers Telco-Scale Visibility at Dramatically Lower Costs

Mount Laurel, NJ, December 01, 2022 --(PR.com)-- NetQuest Corporation, a global leader of advanced cyber intelligence solutions, today announced its new Network Security Broker (NSB)...
Tucson, AZ, November 25, 2022 –(PR.com)– Microvascular Therapeutics (MVT), a clinical stage biotechnology company based in Tucson, Arizona, announced the appointment of Marty Rosenberg to the MVT Board of Scientific Advisors. Mr. Rosenberg brings a broad experience with the clinical development and global regulatory approval process for diagnostic pharmaceuticals across all modalities.

“I am very happy to join MVT’s Scientific Advisory Board. I have, in the past been involved in clinical development of DMP-115 and two other ultrasound contrast agents developed by Evan Unger, the founder of MVT. I will be happy to contribute to the further clinical development and ultimately approval of MVT-100,” said Mr. Rosenberg.

Dr. Rosenberg is a graduate of Temple University School of Medicine and trained in general surgery at Albert Einstein Medical Center in Philadelphia. He joined Squibb Diagnostics in 1990 and worked on the clinical…

Read more…

Popular Articles